MINERALYS THERAPEUTICS INC (MLYS) Stock Balance Sheet
NASDAQ:MLYS - Nasdaq - US6031701013 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 664.00K | 643.00K | 87.70M | 10.61M | 1.41M | |||
| Cash Equivalents | 113.43M | 48.66M | N/A | N/A | N/A | |||
| Marketable Securities | 84.10M | 187.26M | 22.41M | 0.00 | N/A | |||
| Other Current Assets | 7.16M | 12.54M | 2.70M | 510.00K | 57.00K | |||
| Total Current Assets | 205.35M | 249.10M | 112.81M | 11.12M | 1.47M | |||
| Non-Current Assets | ||||||||
| PPE Net | 53.00K | N/A | N/A | N/A | N/A | |||
| Investments And Advances | 0.00 | 2.48M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 499.00K | 51.00K | 1.63M | 3.00K | 20.00K | |||
| Total Non-Current Assets | 552.00K | 2.53M | 1.63M | 3.00K | 20.00K | |||
| TOTAL ASSETS | 205.90M | 251.64M | 114.44M | 11.13M | 1.49M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 4.50M | |||
| Accrued Expenses | 14.17M | 9.88M | 6.16M | 4.29M | 54.00K | |||
| Accounts Payable | 479.00K | 601.00K | 1.91M | 763.00K | 529.00K | |||
| Other Current Liabilities | N/A | N/A | 649.00K | 342.00K | -1.00K | |||
| Total Current Liabilities | 14.65M | 10.48M | 8.07M | 5.05M | 5.08M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 14.65M | 10.48M | 8.07M | 5.05M | 5.08M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -302.52M | -124.71M | -52.81M | -23.01M | -3.60M | |||
| Additional Paid In Capital | 493.77M | 365.86M | 540.00K | 85.00K | 5.00K | |||
| Common Shares | 5.00K | 4.00K | 158.65M | 29.00M | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | 1.00K | |||
| Shares Outstanding | 49.82M | 41.13M | 37.06M | 37.06M | 37.06M | |||
| Tangible Book Value per Share | 3.84 | 5.86 | -1.41 | -0.62 | -0.10 | |||
| Total Shareholders' Equity | 191.26M | 241.15M | 106.38M | 6.07M | -3.60M | |||
| TOTAL LIABILITIES AND EQUITY | 205.90M | 251.64M | 114.44M | 11.13M | 1.49M | |||
| Statistics | ||||||||
| Current Ratio | 14.02 | 23.76 | 13.98 | 2.20 | 0.29 | |||
| Return On Assets (ROA) | -86.36% | -28.57% | -26.04% | -174.45% | -230.55% | |||
| Return On Equity (ROE) | -92.97% | -29.81% | -28.01% | -319.68% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21